Your browser doesn't support javascript.
COVID-19 among fit patients with CLL treated with venetoclax-based combinations.
Fürstenau, Moritz; Langerbeins, Petra; De Silva, Nisha; Fink, Anna Maria; Robrecht, Sandra; von Tresckow, Julia; Simon, Florian; Hohloch, Karin; Droogendijk, Jolanda; van der Klift, Marjolein; van der Spek, Ellen; Illmer, Thomas; Schöttker, Björn; Fischer, Kirsten; Wendtner, Clemens M; Tausch, Eugen; Stilgenbauer, Stephan; Niemann, Carsten U; Gregor, Michael; Kater, Arnon P; Hallek, Michael; Eichhorst, Barbara.
  • Fürstenau M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany. moritz.fuerstenau@uk-koeln.de.
  • Langerbeins P; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • De Silva N; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Fink AM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • von Tresckow J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Simon F; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Hohloch K; Department of Internal Medicine, Hematology and Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland.
  • Droogendijk J; Department of Hematology and Oncology, University Hospital Göttingen, Göttingen, Germany.
  • van der Klift M; Division of Hematology and Oncology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
  • van der Spek E; Division of Hematology and Oncology, Amphia Ziekenhuis Breda, Breda, The Netherlands.
  • Illmer T; Department of Internal Medicine, Ziekenhuis Rijnstate, Arnhem, The Netherlands.
  • Schöttker B; BAG Freiberg-Richter, Jacobasch, Wolf, Illmer, Dresden, Germany.
  • Fischer K; Hämatologisch-onkologische Schwerpunktpraxis Würzburg, Würzburg, Germany.
  • Wendtner CM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Tausch E; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, German CLL Study Group, Munich Clinic Schwabing, Munich, Germany.
  • Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Niemann CU; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Gregor M; Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany.
  • Kater AP; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Hallek M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
  • Eichhorst B; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Leukemia ; 34(8): 2225-2229, 2020 08.
Article in English | MEDLINE | ID: covidwho-619295
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Coronavirus Infections / Betacoronavirus Type of study: Cohort study / Diagnostic study / Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-0941-7

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Coronavirus Infections / Betacoronavirus Type of study: Cohort study / Diagnostic study / Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-0941-7